CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

September 22, 2020
Open Access

Immunotherapy in prostate cancer: current state and future perspectives

Therapeutic Advances in Urology
Shivani HandaAshutosh Tewari
September 18, 2020
Open Access

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia

Journal for Immunotherapy of Cancer
Pinar Ataca AtillaErden Atilla
September 17, 2020
Open Access

Anti-CD20 treatment for B-cell malignancies: current status and future directions

Expert Opinion on Biological Therapy
Christian KleinTina Nielsen
September 19, 2020
Open Access

BCMA-targeted immunotherapy for multiple myeloma

Journal of Hematology & Oncology
Bo YuDelong Liu
September 19, 2020
Open Access

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Ernesto BockampDetlef Schuppan
September 22, 2020
Case Report

Philadelphia chromosome-positive acute lymphoblastic leukemia: a case report

Annals of Palliative Medicine
Xingbin DaiXuejun Zhu
September 19, 2020

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer

Expert Review of Clinical Pharmacology
Jeffrey A Rappaport, Scott A Waldman
September 18, 2020

Central nervous system injury from novel cancer immunotherapies

Current Opinion in Neurology
Sebastian F WinterJorg Dietrich
September 25, 2020

Current developments in the combination therapy of relapsed/refractory multiple myeloma

Expert Review of Anticancer Therapy
Kathryn T MaplesR Donald Harvey
September 22, 2020
Open Access

Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography

Molecular Therapy. Methods & Clinical Development
Julia TransfiguracionAmine A Kamen
September 20, 2020
Open Access

Genetically engineered T cells for cancer immunotherapy

Signal Transduction and Targeted Therapy
Dan LiWei Wang
September 22, 2020

TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacy

Journal of Biopharmaceutical Statistics
Pin LiYuan Ji
September 19, 2020
Open Access

Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy

International Journal of Molecular Sciences
Keyur PatelAshesh P Shah
September 17, 2020
Open Access

Distribution Measurements of Chimeric Antigen Receptor-Modified T Cells Against CD19

Zhitao YingJun Zhu
September 25, 2020
Open Access

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data

Concetta RafanielloAnnalisa Capuano
September 23, 2020
Open Access

Emerging immunotherapies in multiple myeloma

BMJ : British Medical Journal
Urvi A Shah, Sham Mailankody

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved